Navigation Links
IBT Laboratories Names Maureen Loftus President and Chief Operating Officer
Date:7/1/2008

s experience as a management consultant to Fortune 500 companies on strategic, operational, and organizational issues. Ms. Loftus earned her undergraduate degree in business administration at Washington University's John M. Olin School of Business in St. Louis, and holds a master's degree in management from Kellogg Graduate School of Business at Northwestern University.

"This is an exciting time for IBT Labs, and I am thrilled to be part of it," said Ms. Loftus. "The immunology and allergy arena is becoming an increasingly important niche market for testing and research, particularly with the broader development of protein-based therapeutics. These drugs work by triggering the body's immune system. IBT's assays can be used to determine the subset of the population that will benefit from the therapeutic. Equally important -- our assays can identify whether a person is likely to have a potentially fatal allergic response -- before the doctor prescribes the drug. The FDA now requires immunotoxicology testing for all drug development. IBT's expertise in immunology and allergy, and its strong track record of new assay development aligns it strategically with the growing demands -- from biomarker and drug-development research to clinical trials and diagnostic testing."

Commenting on Ms. Loftus' appointment, IBT Lab's Executive Chairman, Laurence McCarthy, Ph.D., said "Maureen is an experienced leader and has managed high-growth organizations over the last 12 years. Her leadership will be essential as the company looks to capitalize on growing demand for its diagnostic-testing services, assay development, and outsourced clinical-trial testing."

About IBT Laboratories

A clinical diagnostic and research laboratory specializing in immunology and allergy testing, IBT tests patient samples for physicians, hospitals, and commercial reference labs from around the globe. IBT also provides biomarker and immunotoxicology testing services to pharmaceutical
'/>"/>

SOURCE IBT Laboratories
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2009 First Quarter Earnings
2. BioNeutral Laboratories Announces the Appointment of Stephen Browand as a Director to Head Military, Homeland Security and Governmental Affairs
3. ARUP Laboratories ARUP Consult(R) Recognized as a Computerworld Honors Program Laureate
4. Frontage Laboratories Completes Acquisition of Advanced Biomedical Research, Inc. (ABR)
5. Barrier Therapeutics to Merge Into Stiefel Laboratories
6. ARUP Laboratories Partners With Pathology Service Associates
7. Fontus Pharmaceuticals Acquires Nephrology and Endocrinology Drug from Roche Laboratories Inc.
8. Cato Research and Neuland Laboratories Form Cato Research Neuland India, Ltd.
9. Forest Laboratories, Inc. and Laboratorios Almirall, S.A. to Host Webcast to Discuss Aclidinium Bromide Data Presentations at the American Thoracic Society Annual Congress
10. Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement
11. IDEXX Laboratories Announces First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... research platform uses a laser to measure ... stress and heating, an approach likely to ... and batteries., This new technique, called nanomechanical ... and the surface stress of microscale structures ... the merits of surface-stress influence on mechanical ...
(Date:8/28/2014)...  Next month, executives from clinical trial marketing firm BBK ... with Patient-Centered Clinical Trials 2014 , to be held ... , September 4-5. Patient recruitment experts Bonnie A. Brescia ... will share insights on the benefits of employing an effective ... from media to mobile apps – can be used to ...
(Date:8/28/2014)... TALLAHASSEE, Fla. Exciting new work by a Florida ... molecular system that can take your temperature, emit white ... , And, the molecule looks like a butterfly. , ... and Biomedical Engineering in the FAMU-FSU College of Engineering, ... ago, but has continued to discover that his creation ...
(Date:8/28/2014)... MA (PRWEB) August 28, 2014 ... wholesale construction materials, selected SoundConnect to ... their cloud based audio and web conferencing platform ... to support PrimeSource’s employees’ needs. SoundConnect delivers ... , PrimeSource Building Products will be utilizing ...
Breaking Biology Technology:New analytical technology reveals 'nanomechanical' surface traits 2New analytical technology reveals 'nanomechanical' surface traits 3BBK Worldwide Leads Sessions at Key September Events 2Novel 'butterfly' molecule could build new sensors, photoenergy conversion devices 2PrimeSource Chooses SoundConnect as Collaboration Provider 2
... Sequenom, Inc. (NASDAQ: SQNM ), a life ... it and its subsidiary Sequenom Center for Molecular Medicine® ... from Silicon Valley Bank’s San Diego-based team. Sequenom will ... and commercialization of new products and other near term ...
... coated with a drug-loaded polymer in an attempt to ... neurological symptoms, such as those associated with an epileptic ... study published today, 2 June 2011, in IOP Publishing,s ... a novel technology to precisely modulate individual neurons in ...
... Female mosquitoes are efficient carriers of deadly diseases such as ... million deaths and hundreds of millions of cases. ... these mosquitoes use exhaled carbon dioxide as a vital cue. ... of mosquitoes, which would help control the spread of diseases ...
Cached Biology Technology:Sequenom Enters Into New $30.0 Million Credit Facility 2Sequenom Enters Into New $30.0 Million Credit Facility 3Sequenom Enters Into New $30.0 Million Credit Facility 4New technology could inspire brain implant for detecting and treating seizures 2New findings by UCR scientists hold big promise for fight against mosquito-borne diseases 2New findings by UCR scientists hold big promise for fight against mosquito-borne diseases 3
(Date:8/28/2014)... A new study reports that an expansion of marine ... perform key ecological functions. According to investigators from ... at protecting fish have focused on saving the largest ... species that provide key and difficult-to-replace ecological functions. ... are performed by fish species that also are food ...
(Date:8/28/2014)... than traditional cigarettes, but still release toxins into ... USC. , Scientists studying secondhand smoke from e-cigarettes ... harmful particles, with close-to-zero exposure to organic carcinogens. ... in second-hand e-cigarette smoke were found to be ... levels of polycyclic aromatic hydrocarbons cancer-causing organic ...
(Date:8/28/2014)... Minn. A Mayo Clinic researcher and his collaborators ... up and enhance the process of re-engineering cells for ... uses network biology methods to aid stem cell engineering. ... engineering are described in two back-to-back papers in the ... a broad range of uses for all types of ...
Breaking Biology News(10 mins):Study finds marine protected areas inadequate for protecting fish and ocean ecology 2Second-hand e-cig smoke compared to regular cigarette smoke 2New tool aids stem cell engineering for medical research 2
... CITY, Calif. , Dec. 11, 2013  DigitalPersona, ... solutions, today announced that the DigitalPersona ® ... been certified by the National Institute of Standards ... testing program to meet the United States Government,s  ...
... Mothers get all the attention. But a study led by ... conception may play an equally important role in the health ... effects of current Western diets and of food insecurity. ... is found in a range of green leafy vegetables, cereals, ...
... Dec. 10, 2013  KaloBios Pharmaceuticals, Inc. (Nasdaq: ... an ongoing multi-center Phase 1 study of KB004, an ... developing as a treatment for hematologic malignancies. Forty-four ... for chemotherapy have been enrolled in the dose ...
Cached Biology News:DigitalPersona FingerJet Recognition Engine Top Performer in Recent MINEX Testing 2You are what your father eats 2KaloBios Announces Preliminary Phase 1 Results in Advanced Hematologic Malignancies with KB004, an Anti-EphA3 Monoclonal Antibody 2KaloBios Announces Preliminary Phase 1 Results in Advanced Hematologic Malignancies with KB004, an Anti-EphA3 Monoclonal Antibody 3KaloBios Announces Preliminary Phase 1 Results in Advanced Hematologic Malignancies with KB004, an Anti-EphA3 Monoclonal Antibody 4KaloBios Announces Preliminary Phase 1 Results in Advanced Hematologic Malignancies with KB004, an Anti-EphA3 Monoclonal Antibody 5